Navigation Links
Comprehend Presents Clinical Intelligence for Data-Driven Decisions
Date:9/25/2017

Comprehend, the leader in Clinical Intelligence software, will be presenting multiple case studies, presentations and demonstrations at SCDM 2017, held September 24-27, 2017 in Orlando. In response to an increasing demand from data managers, medical review teams and CRO partners for more automated capabilities across evolving data, Comprehend delivers real-time visualization, reporting and workflows for data integrated across portfolios, studies, systems and CROs. The result is reduced time, effort and complexity for effective data analysis and speed to insights and action.

“With changes in regulations, an increased focus on therapeutic treatments and constantly changing environments, pharmaceuticals and biotech companies are at risk of significant data delays,” said Rick Morrison, CEO of Comprehend. “We’re focused on enabling a faster, more reliable method of managing clinical trials, helping data management teams see and respond to real-time trends, outliers and issues before they reach criticality.”

Data management and medical review teams can learn more about these solutions at the following sessions:    
Comprehend Exhibit Booth #608 - including demonstrations of self-service analytics, personalized dashboards, centralized monitoring, graphical patient profiles, dynamic line listings and CRO oversight. Stop by and “Spin the Wheel” to win gifts.

Panel Discussion, "Bridging the Clinical-Data Divide to Empower Sites, Monitors & Data Managers”
Speaker: Rick Morrison, CEO, Comprehend Systems
Monday, September 25, 2017 at 10:45am ET
This presentation provides a strategic look at how data management has transformed over the years and what a “fully engaged” team will look like in the future.
Session: SDV - What is it good for? Absolutely Nothing!

Presentation, "Using Clinical Intelligence to Execute Centralized Monitoring in Evolving Operations”
Speaker: Kenneth Wu, MS, MBA, of Kenneth Wu and Associates LLC
Tuesday, September 26, 2017 at 8:30am ET
This presentation will provide a case study example of how automation has enabled a pharmaceutical manufacturer to improve productivity, decrease investigation time and reduce risk through real-time analysis, monitoring and tasks on safety concerns
Session: Fail-Safe Central Data Monitoring in RBM - How Do We Achieve It?

Presentation, "The Race is On...Clinical Intelligence Helps Speed Oncology Drugs to Market”
Speaker: Jud Gardner, CTO, Comprehend Systems
Tuesday, September 26,, 2017 at 10:45am ET
Jud Gardner presents an interesting case study of how a leading pharmaceutical was able to speed both access to data and insightful results to help data managers successfully support the delivery of a new drug to market.
Session: Improving Efficiency and Effectiveness in Data Management of Oncology Studies

In addition, session attendees who stop by the booth can receive a copy of Comprehend's CRO Oversight Benchmark Report. Comprehend surveyed more than 100 leading life sciences leaders to deliver insight into Sponsor goals, challenges and best practices for continuous CRO oversight. The downloadable report covers how program, study and vendor oversight teams are approaching data management to address ICH E6 (R2), best practices for Quality Agreements and Oversight Plans, and a roadmap to continuous CRO Oversight.

About Comprehend Systems, Inc.
Comprehend offers a suite of Clinical Intelligence applications that enables ClinOps Execs, Data Managers and Medical Monitors to significantly improve the speed, safety and quality of a portfolio of clinical trials. Across studies, sites, systems and CROs, Comprehend's Clinical Intelligence Suite is particularly effective for centralized monitoring, risk monitoring, CRO oversight and collaboration, data review and medical monitoring initiatives. With powerful capabilities to intelligently unify, monitor, and analyze clinical data across CROs, studies and systems, Comprehend gives life sciences companies the ability to address the most difficult and complex FDA guidelines for quality, risk and oversight. Comprehend: the speed to quality results. For more information, please go to Comprehend.com.

Read the full story at http://www.prweb.com/releases/2017/09/prweb14728341.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Atreo Group Presents Pneumatic Tube System Upgrade Options at American Society for Healthcare Engineering Conference
2. LabRoots Presents an Educational Webinar Exploring Advances in Testosterone Testing
3. Ovation Fertility™ Presents Reproductive Technology Advancements at Renowned ESHRE Conference July 2 - 5 in Geneva, Switzerland
4. WEDI Presents Testimony to HHS National Committee on Vital and Health Statistics
5. Asymmetrex Presents Adult Tissue Stem Cell Counting at the Alliance for Regenerative Medicine’s First Partnering Conference, May 22-23
6. E&I Cooperative Services Presents VWR with Partner of the Year Award
7. Biostage Presents Positive Preclincal Data of Cellspan Esophageal Implant at Society For Biomaterials 2017 Annual Meeting and Exposition
8. Nektar Therapeutics Presents New Preclinical Data for its Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting
9. Park Systems Presents Analytical Methods with Atomic Force Microscopy at the Advanced Coatings and Characterization Conference in Houston April 11, 2017
10. Vortex Biosciences Presents Studies at AACR That Demonstrate Use of the VTX-1 System for Isolating and Analyzing Circulating Tumor Cells for Cancer Research
11. LabRoots Presents an Educational Webinar Exploring the Challenges and Opportunities of Mass Spectrometry in the Clinical Lab
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... ... Andi Purple announced Dr. Suneel I. Sheikh, the co-founder, CEO and chief research ... Inc. has been selected for membership in ARCS Alumni Hall of Fame ...
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit is back for its ... 2018 in San Francisco, CA. The Summit brings together current and former FDA office ... directors and government officials from around the world to address key issues in device ...
(Date:10/11/2017)... HILLS, Calif. , Oct. 11, 2017  SkylineDx today ... (ICR) and University of Leeds ... risk-stratify patients with multiple myeloma (MM), in a multi-centric Phase ... University of Leeds is the sponsor ... and ICR will perform the testing services to include high-risk ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal ... the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and ...
Breaking Biology Technology:
(Date:4/4/2017)...   EyeLock LLC , a leader of iris-based ... Patent and Trademark Office (USPTO) has issued U.S. Patent ... an iris image with a face image acquired in ... 45 th issued patent. "The ... the multi-modal biometric capabilities that have recently come to ...
(Date:3/30/2017)... 2017 Trends, opportunities and forecast in this ... technology (fingerprint, AFIS, iris recognition, facial recognition, hand geometry, ... end use industry (government and law enforcement, commercial and ... and others), and by region ( North America ... Asia Pacific , and the Rest of the ...
(Date:3/24/2017)... March 24, 2017 The Controller General of Immigration ... Abdulla Algeen have received the prestigious international IAIR Award for ... Continue Reading ... ... Deputy Controller Abdulla Algeen (small picture on the right) have received the ...
Breaking Biology News(10 mins):